Verastem (VSTM) Other Non-Current Liabilities (2012 - 2025)
Verastem (VSTM) recorded quarterly Other Non-Current Liabilities of $35.6 million in Q4 2025, down 26.18% quarter-over-quarter from $48.3 million in Q3 2025, and down 38.75% on a YoY basis from $58.2 million in Q4 2024.
Verastem (VSTM) Other Non-Current Liabilities (2012 - 2025) Analysis & Trends
Verastem's Other Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $35.6 million for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities fell 38.75% year-over-year to $35.6 million; the TTM figure through Dec 2025 stood at $35.6 million (down 38.75% YoY), while the FY2025 annual figure was $35.6 million, down 38.75% from the prior year.
- Other Non-Current Liabilities was $35.6 million for Q4 2025 at Verastem, down from $48.3 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $58.2 million in Q4 2024 to a low of $51000.0 in Q3 2023.
- Historically, Other Non-Current Liabilities has averaged $32.9 million across 3 years, with a median of $35.6 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities soared 51150.98% in 2024, then sank 38.75% in 2025.
- A 3-year view of Other Non-Current Liabilities shows it stood at $51000.0 in 2023, then soared by 114015.69% to $58.2 million in 2024, then sank by 38.75% to $35.6 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $35.6 million (Q4 2025), $48.3 million (Q3 2025), and $7.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.65 Mn |
| Sep 30, 2025 | 48.29 Mn |
| Jun 30, 2025 | 7.55 Mn |
| Mar 31, 2025 | 54.75 Mn |
| Dec 31, 2024 | 58.20 Mn |
| Sep 30, 2024 | 26.14 Mn |
| Sep 30, 2023 | 51,000.00 |
| Jun 30, 2020 | 870,000.00 |
| Mar 31, 2020 | 870,000.00 |
| Dec 31, 2019 | 870,000.00 |
| Sep 30, 2019 | 870,000.00 |
| Jun 30, 2019 | 500,000.00 |
| Mar 31, 2019 | 500,000.00 |
| Dec 31, 2018 | 1.12 Mn |
| Sep 30, 2018 | 566,000.00 |
| Jun 30, 2018 | 399,000.00 |
| Mar 31, 2018 | 101,000.00 |
| Dec 31, 2017 | 151,000.00 |
| Sep 30, 2017 | 201,000.00 |
| Jun 30, 2017 | 248,000.00 |